VEGF-dependent and alternative mechanisms of angiogenesis
Issues in anti-angiogenic cancer therapy, including:
Immunomodulation
Inherent /acquired resistance
Lack of validated predictive and prognostic biomarkers
Enhanced invasiveness / metastasis, and
Treatment-induced metastasis
Controversies regarding the function of vascular normalization
The validity of hypertension as a physiological biomarker
Past Events
Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy 2014 - 19-20 Jun 2014, New York Academy of Sciences Conference Center, New York City, New York, United States (42534)
Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy 2026
Important
Please, check "Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Hematology, Immunology, Oncology, Pharma
